Product details
Catalog number RA1501.5G
Price for RA1501.5G
Size / count 5 g
TentaGel® resins are grafted copolymers consisting of a low crosslinked polystyrene matrix on which polyethylene glycol (PEG or POE) is grafted via an ethyl ether group which increases stability towards acid treatment and minimizes PEG-leaching. The graft copolymer shows modified physicochemical properties which are highly dominated by the PEG moiety (and no longer by the polystyrene matrix) and has hydrophobic and hydrophilic properties. These copolymers are pressure stable and can be used in batch processes as well as under continuous flow conditions. The PEG spacer is in the range of MW 3000 Da. TentaGel® resins have high diffusion rates and excellent swelling in a wide range of solvents from e.g. toluene to water. TentaGel® R resin is a special designed resin for research use. Long peptide sequences (up to 100 residues), difficult sequences and PNA´s are synthesized on this support. The resin shows an increased swelling volume and a significant lower loading. This resin is functionalized with the TFA-labile 4- (hydroxymethyl) -phenoxyacetic acid linker and is an alternative to the PHB resins. Cleavage is established with 95% TFA. D-amio acid on request.
The catalog number for Fmoc-Ala TentaGel® R HMPA Resin is RA1501.5G.
Fmoc-Ala TentaGel® R HMPA Resin is available in the following size(s): 5 g.
Fmoc-Ala TentaGel® R HMPA Resin is currently made to order / not held in immediate stock. Contact us for lead time.
TentaGel® resins are grafted copolymers consisting of a low crosslinked polystyrene matrix on which polyethylene glycol (PEG or POE) is grafted via an ethyl ether group which increases stability towards acid treatment and minimizes PEG-leaching. The graft copolymer shows modified physicochemical pro
Molecular weight information, where applicable, is listed on the datasheet under target details, useful for confirming the correct band on western blot.
Lead times depend on the product type: custom polyclonal antibodies typically take 12-14 weeks, monoclonal antibodies 15-17 weeks, made-to-order recombinant proteins 4-8 weeks, and made-to-order recombinant antibodies 6-8 weeks. These are estimates and may shift due to production delays.
A recommended dilution range for each validated application is provided on the datasheet, but optimal dilution should be titrated for your specific experimental system, sample type, and detection method.